Paper - WANFANG MED ONLINE

You Position: Home > Paper

Clinical microbial thinking in empirical anti?infective treatment of community acquired pneumonia

( views:0, downloads:0 )

Author:: No author available

Journal Title:: Chinese Journal of Tuberculosis and Respiratory Diseases

Issue:: 6

DOI:: 10.3760/cma.j.cn112147-20201019-01051

Key Word:: No keyword available

Abstract：社区获得性肺炎（CAP）是一种社区发生的重要急性感染病，早期充分治疗可以改善预后。临床抗感染实践必须要培养临床微生物思维，即对病原体及其耐药性的评估。指南推荐的两种方案为CAP治疗的多样化提供了可能，抗菌药物选择的多样化是遏制耐药发生发展的关键之所在。本文从CAP主要病原体及耐药性的流行病学与个体化评、CAP经验性治疗中两个方案的临床实践以及病情严重程度对选择治疗方案的影响三方面展开阐述具有临床微生物思维的经验性抗感染治疗可以最大程度减少CAP中过度的抗感染治疗。

Reference

[1]徐洁.HUC-MSCs对变应性鼻炎鼻上皮细胞糖皮质激素受体表达的影响[D].2018.
[2]林颖,胡锦章,颛孙永勋,等.骨髓间充质干细胞外泌体调节哮喘小鼠Foxp3+ Treg/Th17的平衡[J].2018,(17).
[3]Cruz, Fernanda F.,Borg, Zachary D.,Goodwin, Meagan,etc.Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice[J].2015,4(11).
[4]van Niel, Guillaume,D'Angelo, Gisela,Raposo, Graca.Shedding light on the cell biology of extracellular vesicles[J].2018,19(4).
[5]Gounni AS,Saffar AS.The molecular mechanisms of glucocorticoids-mediated neutrophil survival.[J].2011,12(4).
[6]Zikuan,Leng,Rongjia,Zhu,Wei,Hou,etc.Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.[J].2020,11(2).
[7]LeRoux-Williams,M.,Tashkin,D.P.,Weiss,D.J.,etc.A placebo-controlled, randomized trial of mesenchymal stem cells in COPD[J].2013,143(6).
[8]Popov B,Su X,Serikov V,etc.Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.[J].2007,179(3).
[9]Cai,T.,Qu,C.,Sun,L.,etc.Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis[J].2012,10(5).
[10]Agnes T. Reiner,Kenneth W. Witwer,Bas W.M. van Balkom,etc.Concise Review: Developing Best‐Practice Models for the Therapeutic Use of Extracellular Vesicles[J].2017,6(8).
[11]Young-Sup, Yoon,Jong-Seon, Park,Tengiz, Tkebuchava,etc.Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction.[J].2004,109.
[12]García-Olmo Damián,García-Arranz Mariano,Herreros Dolores,etc.A Phase I Clinical Trial of the Treatment of Crohn’s Fistula by Adipose Mesenchymal Stem Cell Transplantation[J].2005,48(7).
[13]Cristina,Grange,Renata,Skovronova,Federica,Marabese,etc.Stem Cell-Derived Extracellular Vesicles and Kidney Regeneration.[J].2019,8(10).
[14]Monsei, Antoine,Zhu, Ying-gang,Gennai, Stephane,etc.Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice[J].2015,192(3).
[15]Yen-Ta Chen,Cheuk-Kwan Sun,Yu-Chun Lin,etc.Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction[J].2011,9(1).
[16]Bashtar M,Baharvand H,Bagheri M,etc.Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.[J].2007,10(4).
[17]Sugiura H,Ichinose M.Oxidative and nitrative stress in bronchial asthma.[J].2008,10(4).
[18]Zhang, Li-Bo,He, Min.Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis[J].2019,54.
[19]Kerkhof, Marjan,Tran, Trung N.,Soriano, Joan B.,etc.Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population[J].2018,73(2).
[20]Rodriguez, Juan M.,Monsalves-Alvarez, Matias,Henriquez, Sandra,etc.Glucocorticoid resistance in chronic diseases[J].2016,115.
[21]Michael Harpole,Justin Davis,Virginia Espina.Current state of the art for enhancing urine biomarker discovery[J].2016,13(6).
[22]Du, Yu-mo,Zhuansun, Yong-xun,Chen, Rui,etc.Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma.[J].2018,363(1).
[23]Gwendal Lazennec,Christian Jorgensen.Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?[J].2008,26(6).
[24]Feng, Yonghuai,Zhu, Rongjia,Shen, Jing,etc.Human Bone Marrow Mesenchymal Stem Cells Rescue Endothelial Cells Experiencing Chemotherapy Stress by Mitochondrial Transfer Via Tunneling Nanotubes[J].2019,28(10).
[25]Sinclair Kenneth Andrew,Yerkovich Stephanie Terase,Hopkins Peter Mark-Anthony,etc.Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung[J].2016,7(1).
[26]Donald G, Phinney,Michelangelo, Di Giuseppe,Joel, Njah,etc.Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs.[J].2015,6.
[27]Sudeepta, Aggarwal,Mark F, Pittenger.Human mesenchymal stem cells modulate allogeneic immune cell responses.[J].2005,105(4).
[28]Lumei, Chi,Yujing, Huang,Ying, Mao,etc.Tail Vein Infusion of Adipose-Derived Mesenchymal Stem Cell Alleviated Inflammatory Response and Improved Blood Brain Barrier Condition by Suppressing Endoplasmic Reticulum Stress in a Middle Cerebral Artery Occlusion Rat Model.[J].2018,24(Spec ).
[29]Jacques Galipeau,Luc Sensébé.Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities[J].2018,22(6).
[30]Yu-Chin,Huang,Liang-Chuan,Lai.The potential roles of stem cell-derived extracellular vesicles as a therapeutic tool.[J].2019,7(22).
[31]Panes, Julian,Garcia-Olmo, Damian,Van Assche, Gert,etc.Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial[J].2016,388(10051).
[32]Su M,Metcalfe.Mesenchymal stem cells and management of COVID-19 pneumonia.[J].2020,5.
[33]Trevor,J.L.,Deshane,J.S..Refractory asthma: Mechanisms, targets, and therapy[J].2014,69(7).
[34]Eisenhauer PL,Suratt BT,Spees JL,etc.Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells.[J].2008,177(7).
[35]Dominici M,Le Blanc K,Mueller I,etc.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J].2006,8(4).
[36]Volarevic, Vladislav,Gazdic, Marina,Markovic, Bojana Simovic,etc.Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential[J].2017,43(5).
[37].Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer[J].2017,196(10).
[38]Rajesh Alphonse,Bernard Thébaud,Paul Waszak,etc.Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats.[J].2012,21(15).
[39]Ai, Wen-Jia,Li, Jie,Lin, Shao-Mang,etc.R-Smad Signaling-Mediated VEGF Expression Coordinately Regulates Endothelial Cell Differentiation of Rat Mesenchymal Stem Cells[J].2015,24(11).
[40]Akyurekli, Celine,Le, Yevgeniya,Richardson, Richard B.,etc.A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles[J].2015,11(1).
[41]Kenneth W. Witwer,"name":"Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA",Bas W.M. Van Balkom,etc.Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications[J].2019,8(1).
[42]Glassberg,M.K.,Minkiewicz,etc.Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial[J].2017,151(5).
[43]Yufang Shi,Yu Wang,Qing Li,etc.Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.[J].2018,14(8).
[44].Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer[J].2016.
[45]Ciro Tetta,Stefania Bruno,Valentina Fonsato,etc.The role of microvesicles in tissue repair[J].2011,7(2).
[46]NATIVIDAD Cuende,JOHN E.J. RASKO,MICKEY B.C. KOH,etc.Cell, tissue and gene products with marketing authorization in 2018 worldwide[J].2018,20(11).
[47]E. Y. Plotnikov,T. G. Khryapenkova,A. K. Vasileva,etc.Cell‐to‐cell cross‐talk between mesenchymal stem cells and cardiomyocytes in co‐culture[J].2008,12(5a).
[48]Steven M, Devine,Carrington, Cobbs,Matt, Jennings,etc.Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.[J].2003,101.
[49]Babenko, Valentina A.,Silachev, Denis N.,Popkov, Vasily A.,etc.Miro1 Enhances Mitochondria Transfer from Multipotent Mesenchymal Stem Cells (MMSC) to Neural Cells and Improves the Efficacy of Cell Recovery[J].2018,23(3).
[50]Trounson, Alan,McDonald, Courtney.Stem Cell Therapies in Clinical Trials: Progress and Challenges[J].2015,17(1).
[51]Hong Gyong Hwa,Kwon Hyouk-Soo,Lee Kyoung Young,etc.hMSCs suppress neutrophil-dominant airway inflammation in a murine model of asthma[J].2017,49(1).
[52]Biljana, Ljujic,Marija, Milovanovic,Vladislav, Volarevic,etc.Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.[J].2013,3.
[53]Fang Shu-Bin,Zhang Hong-Yu,Jiang Ai-Yun,etc.Human iPSC-MSCs prevent steroid-resistant neutrophilic airway inflammation via modulating Th17 phenotypes[J].2018,9(1).
[54]Poltavtseva, R. A.,Poltavtsev, A. V.,Lutsenko, G. V.,etc.Myths, reality and future of mesenchymal stem cell therapy[J].2019,375(3).
[55]Xiaohua, Zhu,Mohamed, Badawi,Steven, Pomeroy,etc.Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.[J].2017,6(1).
[56]Martin, Breitbach,Toktam, Bostani,Wilhelm, Roell,etc.Potential risks of bone marrow cell transplantation into infarcted hearts.[J].2007,110(4).
[57]A J, Friedenstein,K V, Petrakova,A I, Kurolesova,etc.Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.[J].1968,6(2).
[58]Seo, Yoojin,Kim, Hyung-Sik,Hong, In-Sun.Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics[J].2019,2019(2).
[59]Lathrop,M.J.,Brooks,E.M.,Bonenfant,N.R.,etc.Mesenchymal stromal cells mediate aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the th17 signaling pathway[J].2014,3(2).
[60]Ntolios Paschalis,Manoloudi Eleni,Tzouvelekis Argyris,etc.Longitudinal outcomes of patients?enrolled in a phase Ib clinical trial of the adipose‐derived stromal cells‐stromal vascular fraction in idiopathic pulmonary fibrosis[J].2018,12(6).
[61]Ringden O,Sundberg B,Le Blanc K,etc.Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.[J].2004,363(9419).
[62]Vladislav, Volarevic,Bojana Simovic, Markovic,Marina, Gazdic,etc.Ethical and Safety Issues of Stem Cell-Based Therapy.[J].2018,15(1).
[63]张旻,张雪,周新.2017年《重症哮喘诊断与处理中国专家共识》解读[J].2018,(6).